SMPD1 and Miyoshi myopathy: Recent insights into lipid metabolism in MM indicate an important role for altered lipid homeostasis, as increased acid sphingomyelinase (ASM, which converts sphingomyelin to ceramide) expression contributes to drug resistance to melphalan and bortezomib, a drug-resistance phenotype that could be transferred to chemosensitive cells through exosomes [214].